Excelsior Medical Co Stock Price To Sales
| 4104 Stock | TWD 87.00 0.20 0.23% |
Excelsior Medical Co fundamentals help investors to digest information that contributes to Excelsior Medical's financial success or failures. It also enables traders to predict the movement of Excelsior Stock. The fundamental analysis module provides a way to measure Excelsior Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Excelsior Medical stock.
Excelsior |
Excelsior Medical Co Company Price To Sales Analysis
Excelsior Medical's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current Excelsior Medical Price To Sales | 1.40 X |
Most of Excelsior Medical's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Excelsior Medical Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
| Competition |
Based on the latest financial disclosure, Excelsior Medical Co has a Price To Sales of 1.4014 times. This is 93.45% lower than that of the Health Care Providers & Services sector and 70.68% lower than that of the Health Care industry. The price to sales for all Taiwan stocks is 87.73% higher than that of the company.
Excelsior Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Excelsior Medical's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Excelsior Medical could also be used in its relative valuation, which is a method of valuing Excelsior Medical by comparing valuation metrics of similar companies.Excelsior Medical is currently under evaluation in price to sales category among its peers.
Excelsior Fundamentals
| Return On Equity | 0.0825 | |||
| Return On Asset | 0.0241 | |||
| Profit Margin | 0.1 % | |||
| Operating Margin | 0.08 % | |||
| Current Valuation | 7.28 B | |||
| Shares Outstanding | 148.21 M | |||
| Shares Owned By Insiders | 40.16 % | |||
| Shares Owned By Institutions | 2.26 % | |||
| Price To Earning | 15.27 X | |||
| Price To Book | 1.20 X | |||
| Price To Sales | 1.40 X | |||
| Revenue | 6.57 B | |||
| Gross Profit | 1.37 B | |||
| EBITDA | 1.09 B | |||
| Net Income | 607.15 M | |||
| Cash And Equivalents | 3.9 B | |||
| Cash Per Share | 27.63 X | |||
| Total Debt | 705.38 M | |||
| Debt To Equity | 0.07 % | |||
| Current Ratio | 1.74 X | |||
| Book Value Per Share | 54.98 X | |||
| Cash Flow From Operations | 945.05 M | |||
| Earnings Per Share | 4.58 X | |||
| Target Price | 77.2 | |||
| Number Of Employees | 19 | |||
| Beta | 0.2 | |||
| Market Capitalization | 11.19 B | |||
| Total Asset | 15.11 B | |||
| Retained Earnings | 2.36 B | |||
| Working Capital | 4.72 B | |||
| Current Asset | 11.85 B | |||
| Current Liabilities | 7.12 B | |||
| Z Score | 9.0 | |||
| Annual Yield | 0.04 % | |||
| Five Year Return | 5.67 % | |||
| Net Asset | 15.11 B | |||
| Last Dividend Paid | 3.33 |
About Excelsior Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Excelsior Medical Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Excelsior Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Excelsior Medical Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Excelsior Stock Analysis
When running Excelsior Medical's price analysis, check to measure Excelsior Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Excelsior Medical is operating at the current time. Most of Excelsior Medical's value examination focuses on studying past and present price action to predict the probability of Excelsior Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Excelsior Medical's price. Additionally, you may evaluate how the addition of Excelsior Medical to your portfolios can decrease your overall portfolio volatility.